Glenmark Life Sciences Ltd. (ALIVUS) Share Price Hits Fresh 52-Week High

Glenmark Life Sciences Ltd. traded at Rs 1,386.75, up 0.95% today, after hitting a fresh 52-week high of Rs 1,415.90. Market capitalisation stood at Rs 16,865.73 crore.

Glenmark Life Sciences Ltd. Share Price was at Rs 1,386.75 on 11 August 2026, up Rs 13 or 0.95% from the previous close of Rs 1,373.75, after the stock touched a fresh 52-week high of Rs 1,415.90 in intraday trade. The company’s market capitalisation stood at Rs 16,865.73 crore, placing it among the larger names in the supplied Healthcare sector universe.

For investors searching Glenmark Life Sciences Ltd. Share Price Today, the key verified takeaway is straightforward: the stock entered the 52-week high list, traded in a Rs 1,381.50 to Rs 1,415.90 intraday band, and generated turnover of Rs 0.64 crore on volume of 4,643 shares. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind today’s move.

That still makes the stock relevant in Stock Market Today and Share Market Today screens because a fresh yearly high often draws attention to valuation, profitability and sector position. In this Univest stock analysis, the next points to monitor are price behaviour around the new 52-week peak, the stock’s valuation versus Healthcare benchmarks, and how its return ratios compare with peers.

Glenmark Life Sciences Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,386.75
Previous Close	Rs 1,373.75
Today's Change	+Rs 13 (+0.95%)
Day Open	Rs 1,384.4
Fresh 52-Week High	Rs 1,415.9
Day Low	Rs 1,381.5
Current Volume	4,643
Turnover	Rs 0.64 crore
Market Capitalisation	Rs 16,865.73 crore

Glenmark Life Sciences Ltd. (ALIVUS) traded at Rs 1,386.75. versus the previous close of Rs 1,373.75, a rise of 0.95%. The stock opened at Rs 1,384.4, reached Rs 1,415.9, touched Rs 1,381.5. Reported volume was 4,643.

Glenmark Life Sciences Ltd. Share Price Today reflects a session in which the stock moved above its earlier one-year range and printed a fresh 52-week high of Rs 1,415.90. The day’s data shows a modest gain from the previous close, a firm open, and intraday participation that kept the stock on investor watchlists.

The stock opened at Rs 1,384.40, slightly above the previous close of Rs 1,373.75, and later advanced to Rs 1,415.90, which now stands as the new 52-week high. By the time of the article event, Glenmark Life Sciences Ltd. Share Price was at Rs 1,386.75, still holding onto a gain of Rs 13 for the day, or 0.95%.

The intraday low was Rs 1,381.50, which means the trading band for the session was relatively contained even as the stock registered a new yearly high. That is worth noting because it suggests the move to the 52-week peak occurred without an extreme gap between the day’s low and high. In Market News terms, this was a clean price action event rather than a highly erratic spike.

Turnover stood at Rs 0.64 crore and current volume at 4,643 shares. For traders and long-term investors alike, Glenmark Life Sciences Ltd. Share Price Live action is therefore notable less for a sharp daily percentage surge and more for the fact that the stock has moved into a fresh one-year high zone. That naturally shifts the discussion from intraday movement to whether fundamentals support continued investor attention.

Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 16,865.73 crore
P/E Ratio	40.09x
P/B Ratio	9.77x
ROE	28.21%
ROCE	26.35%

Glenmark Life Sciences Ltd. was valued at a P/E ratio of 40.09x, a P/B ratio of 9.77x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	40.09x
Benchmark Median P/E	20.84x
Benchmark Average P/E	76.55x
Benchmark P/E Range	0x to 3,396.3x
Company P/B Ratio	9.77x
Benchmark Median P/B	1.93x
Company ROE	28.21%
Benchmark Median ROE	10.77%
Company ROCE	26.35%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 16,865.73 crore
Benchmark Median Market Cap	Rs 142.3 crore

Glenmark Life Sciences Ltd. (ALIVUS) is classified under sector: Healthcare.

Glenmark Life Sciences Ltd. (ALIVUS) has a P/E ratio of 40.09x, which is above the benchmark median of 20.84x, a difference of +92.37%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Glenmark Life Sciences Ltd. (ALIVUS) has a ROE of 28.21%, which is above the benchmark median of 10.77%, a difference of +161.93%. Glenmark Life Sciences Ltd. (ALIVUS) has a ROCE of 26.35%, which is above the benchmark median of 13.35%, a difference of +97.38%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.09	9.77	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	66.92	10.59	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,601.85	34.14	7.04	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,513.58	181.97	3.36	13.9	12.97
NGL Fine-Chem Ltd.	NGLFINE	2,118.6	44.48	6.5	27.9	33.91

Glenmark Life Sciences Ltd. (ALIVUS) has a P/E ratio of 40.09x compared with the displayed peer median of 44.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Glenmark Life Sciences Ltd. (ALIVUS) has a market capitalisation of Rs 16,865.73 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Glenmark Life Sciences Ltd.

Investors are watching the stock because today’s move combines a fresh 52-week high with valuation and profitability numbers that stand out against both sector benchmarks and listed peers. The verified dataset highlights price action, relative scale and return ratios as the main reasons Glenmark Life Sciences Ltd. Latest News is being tracked.

• Fresh one-year high: the stock touched Rs 1,415.90, its new 52-week peak.
• Positive daily move: Glenmark Life Sciences Ltd. Share Price Today was up Rs 13, or 0.95%, versus the previous close.
• Large market value: market capitalisation stood at Rs 16,865.73 crore.
• Strong profitability metrics: ROE was 28.21% and ROCE was 26.35%.
• Premium valuation: P/E at 40.09 and P/B at 9.77 sit above sector medians.
• Sector standing: the company’s market cap is far above the supplied Healthcare benchmark median and average.
• Peer position: return ratios compare favourably with most supplied peers, while market cap is the highest in the peer set.

About Glenmark Life Sciences Ltd.

Glenmark Life Sciences Ltd. (ALIVUS) is a listed company being tracked in the Healthcare sector. In today’s Glenmark Life Sciences Ltd. Company News flow, the stock has entered focus because it recorded a fresh 52-week high and moved into the set of closely watched momentum names in the Indian Stock Market.

The supplied dataset identifies the company through its listed symbol ALIVUS and places it within the Healthcare space used for the benchmark and peer comparison in this article. While the event data here is centred on market behaviour rather than a broader company profile, investors following Glenmark Life Sciences Ltd. NSE and Glenmark Life Sciences Ltd. BSE search intent are currently watching the stock for its price action, market capitalisation, valuation ratios and return metrics. On Univest, those figures provide the basis for a fact-led market update without extending beyond the verified data.

Track Glenmark Life Sciences Ltd. Share Price on Univest

Use Glenmark Life Sciences Ltd. (ALIVUS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Univest helps users track Glenmark Life Sciences Ltd. Share Price through live market updates, 52-week levels, valuation ratios, peer comparison and sector context. For investors following Glenmark Life Sciences Ltd. Share Price Live, Glenmark Life Sciences Ltd. Shareholding Pattern, Glenmark Life Sciences Ltd. Market Cap and broader Stock Updates, today’s fresh 52-week high makes the stock worth monitoring on a data-first basis.

On Univest, users can follow Glenmark Life Sciences Ltd. Share Price Today alongside market capitalisation, P/E, P/B, ROE, ROCE and the stock’s position against Healthcare benchmarks. That is especially useful when a stock appears in 52 Week High screens and investors want a single view of price action, fundamental analysis and peer positioning without relying on speculation.

Frequently Asked Questions

What is the latest Glenmark Life Sciences Ltd. Share Price Today?

Ans. Glenmark Life Sciences Ltd. Share Price Today was Rs 1,386.75 at the time of the event. The stock was up Rs 13, or 0.95%, from the previous close of Rs 1,373.75 after touching a fresh 52-week high.

What was the fresh 52-week high for Glenmark Life Sciences Ltd.?

Ans. The stock touched a fresh 52-week high of Rs 1,415.90 in intraday trade. That one-year high is the key verified event behind today’s market attention, even though the supplied data does not identify a company-specific trigger.

How much did Glenmark Life Sciences Ltd. gain today?

Ans. Glenmark Life Sciences Ltd. rose by Rs 13 on the day, which translates into a gain of 0.95%. The move came after a previous close of Rs 1,373.75 and kept the stock in positive territory near its yearly high.

What does today’s price action show for Glenmark Life Sciences Ltd.?

Ans. The stock opened at Rs 1,384.40, moved between Rs 1,381.50 and Rs 1,415.90, and traded at Rs 1,386.75 around the event time. That sequence shows a firm open, a fresh 52-week peak and a still-positive session.

What is the market capitalisation of Glenmark Life Sciences Ltd.?

Ans. Glenmark Life Sciences Ltd. had a market capitalisation of Rs 16,865.73 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 142.30 crore and average of Rs 472.15 crore.

Is Glenmark Life Sciences Ltd. expensive based on P/E and P/B?

Ans. The stock traded at a P/E of 40.09 and a P/B of 9.77. Those figures are above the Healthcare sector median P/E of 20.84 and median P/B of 1.93, indicating a premium to benchmark medians.

How strong are Glenmark Life Sciences Ltd.'s profitability ratios?

Ans. The supplied profitability ratios are strong relative to the benchmark set. ROE stands at 28.21% and ROCE at 26.35%, both above the Healthcare sector median of 10.77% ROE and 13.35% ROCE.

How does Glenmark Life Sciences Ltd. compare with its peers?

Ans. In the supplied peer set, Glenmark Life Sciences Ltd. has the highest market capitalisation at Rs 16,865.73 crore. Its ROE and ROCE are stronger than most peers, while valuation is lower than Beta Drugs and Sai Parenteral's on P/E.

What was the trading volume and turnover in Glenmark Life Sciences Ltd. today?

Ans. The stock recorded current volume of 4,643 shares and turnover of Rs 0.64 crore in the supplied session data. Those figures confirm active trading interest as the stock moved to a fresh 52-week high.

Why is Glenmark Life Sciences Ltd. in the news today?

Ans. Glenmark Life Sciences Ltd. is in the news because it touched a fresh 52-week high of Rs 1,415.90. Investors are also watching its Rs 16,865.73 crore market cap and profitability metrics of 28.21% ROE and 26.35% ROCE.